OrbiMed’s 908 Devices MASS Stock Holding History

OrbiMed’s Portfolio MASS Stock Details MASS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q1	–	Sell	-40,000	Closed	-$2.28M	–	172
2020 Q4	$2.28M	Buy	+40,000	New	+$2.34M	0.02%	144

Other funds holding MASS

AIM

ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

TCM

Tao Capital Management San Francisco, California $119M AUM 87.46% 1-Year Est. Return

CAM

Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

GIM

Granahan Investment Management Waltham, Massachusetts $2.07B AUM 56.45% 1-Year Est. Return

Casdin Capital New York $1.32B AUM 76.62% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

EAM

Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return

OrbiMed's MASS Position: Q1 2021 in Review

OrbiMed sold out of 908 Devices (MASS) in Q1 2021, closing a stake of 40,000 shares — an estimated $2.28M sold.

OrbiMed first reported a position in MASS in Q4 2020 and held it in 1 quarter. The position peaked at $2.28M in Q4 2020. 72 funds tracked by Wall St. Rank hold MASS as of Q1 2021.

OrbiMed reported no remaining 908 Devices position as of Q1 2021 after selling out during the quarter.
OrbiMed sold 40,000 908 Devices shares in Q1 2021, an estimated $2.28M.
OrbiMed first reported a position in 908 Devices in Q4 2020 and held it in 1 quarter.
OrbiMed's 908 Devices position peaked at $2.28M in Q4 2020.
72 funds tracked by Wall St. Rank held 908 Devices as of Q1 2021.

Based on OrbiMed's 13F filing for Q1 2021, filed 17 May 2021.